HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lingli Chen Selected Research

pluronic L61

9/2015Inhibition of Breast Cancer Metastasis by Pluronic Copolymers with Moderate Hydrophilic-Lipophilic Balance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lingli Chen Research Topics

Disease

35Neoplasms (Cancer)
06/2022 - 11/2008
12Breast Neoplasms (Breast Cancer)
01/2017 - 11/2008
9Neoplasm Metastasis (Metastasis)
01/2021 - 09/2013
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2019
7Hepatocellular Carcinoma (Hepatoma)
07/2021 - 01/2009
6COVID-19
06/2021 - 01/2020
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 01/2017
2Acute Lung Injury
06/2022 - 06/2022
2Wounds and Injuries (Trauma)
05/2022 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2018
2Inflammation (Inflammations)
01/2021 - 03/2010
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 01/2018
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2015 - 01/2014
2Fibrosis (Cirrhosis)
01/2015 - 01/2014
2Lung Neoplasms (Lung Cancer)
11/2012 - 01/2012
2Primary angiitis of the central nervous system
04/2010 - 03/2010
1Intellectual Disability (Idiocy)
08/2022
1Lung Injury
06/2022
1Pulmonary Emphysema
05/2022
1Membranous Glomerulonephritis (Membranous Nephropathy)
03/2022
1Parkinson Disease (Parkinson's Disease)
01/2022
1Microsatellite Instability
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Hypertension (High Blood Pressure)
06/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2021
1Klatskin Tumor
01/2021
1Heart Failure
01/2021
1Disease Progression
01/2021
1Infarction (Infarctions)
01/2021
1Myocardial Infarction
01/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
01/2020 - 11/2008
6Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2018
6DNA (Deoxyribonucleic Acid)IBA
06/2011 - 01/2010
5Therapeutic UsesIBA
01/2020 - 11/2012
4Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2018
4Doxorubicin (Adriamycin)FDA LinkGeneric
07/2018 - 09/2012
4Paclitaxel (Taxol)FDA LinkGeneric
11/2016 - 01/2012
4Small Interfering RNA (siRNA)IBA
04/2015 - 11/2012
4Lipid NanoparticlesIBA
09/2013 - 10/2008
4Docetaxel (Taxotere)FDA Link
11/2010 - 11/2008
3CurcuminIBA
01/2022 - 03/2015
3Sorafenib (BAY 43-9006)FDA Link
01/2020 - 03/2015
3SurvivinIBA
11/2012 - 09/2012
3PolymersIBA
06/2011 - 03/2010
2LipopolysaccharidesIBA
06/2022 - 06/2022
2Caspase 3 (Caspase-3)IBA
06/2022 - 01/2020
2AntibodiesIBA
03/2022 - 07/2021
2NivolumabIBA
01/2022 - 01/2020
2MucinsIBA
01/2022 - 01/2021
2Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 01/2020
2Messenger RNA (mRNA)IBA
11/2021 - 10/2019
2Tyrosine Kinase InhibitorsIBA
07/2021 - 01/2020
2LipidsIBA
06/2021 - 02/2010
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2021 - 01/2021
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2021 - 01/2021
2AlbuminsIBA
01/2021 - 11/2020
2C-Reactive ProteinIBA
01/2021 - 01/2021
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 01/2015
2fibrin fragment D (D-dimer)IBA
01/2021 - 11/2020
2Anti-Bacterial Agents (Antibiotics)IBA
07/2020 - 12/2018
2CytokinesIBA
01/2020 - 12/2019
2ErbB Receptors (EGF Receptor)IBA
01/2020 - 11/2008
2Poloxamer (Poloxamer 407)IBA
09/2015 - 11/2012
2EstersIBA
04/2015 - 07/2014
2RNA (Ribonucleic Acid)IBA
07/2014 - 07/2013
2tocophersolanIBA
09/2013 - 11/2012
1Phosphotransferases (Kinase)IBA
06/2022
1Carrier Proteins (Binding Protein)IBA
06/2022
1Caspase 8 (Caspase-8)IBA
06/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022
1Z-Form DNA (Z-DNA)IBA
06/2022
1Interleukin-6 (Interleukin 6)IBA
06/2022
1Monoclonal AntibodiesIBA
04/2022
1McAb NJ001IBA
04/2022
1Galectin 3 (LGALS3)IBA
03/2022
1EuropiumIBA
03/2022
1Peptides (Polypeptides)IBA
01/2022
1Oxidopamine (6 Hydroxydopamine)IBA
01/2022
1Neuroprotective AgentsIBA
01/2022
1pembrolizumabIBA
01/2022
1Immune Checkpoint ProteinsIBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1OsteopontinIBA
11/2021
1Apolipoprotein A-I (Apolipoprotein A1)IBA
06/2021
1ProcalcitoninIBA
01/2021
1Sirtuin 1IBA
01/2021
1Pepsinogen A (Pepsinogen)IBA
01/2021
1Troponin IIBA
01/2021
1mangiferinIBA
01/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2021
1Blood Glucose (Blood Sugar)IBA
07/2020

Therapy/Procedure

17Therapeutics
06/2022 - 10/2008
11Drug Therapy (Chemotherapy)
01/2020 - 11/2008
2Adjuvant Chemotherapy
01/2022 - 01/2017
2Artificial Respiration (Mechanical Ventilation)
07/2020 - 01/2020
2Intravenous Administration
07/2013 - 04/2010
1Pneumonectomy (Lung Volume Reduction)
05/2022
1Hepatectomy
07/2021
1Immunotherapy
01/2021